CS logo
small CS logo
Driscoll Childrens Hospital

Corpus Christi, Texas, United States
Hospital in Corpus Christi, Texas
3533 S Alameda St, Corpus Christi, TX 78411
191 Beds

About Driscoll Childrens Hospital


Driscoll Children's Hospital is a children's hospital located in Corpus Christi, Texas and founded as a charity children's hospital in 1953 by the last-will and testament of Clara Driscoll with the assistance of her primary physician Dr. McIver Furman.
There are 191 beds in Driscoll Childrens Hospital.
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender

Clinical Trials at Driscoll Childrens Hospital


During the past decade, Driscoll Childrens Hospital conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 81 clinical trials were completed, i.e. on average, 137.3% percent of trials that started reached the finish line to date. In the past 5 years, 25 clinical trials started and 31 clinical trials were completed. i.e. 124% of trials that started reached the finish line.

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Driscoll Childrens Hospital" #1 sponsor was "Children's Oncology Group" with 112 trials, followed by "National Cancer Institute (NCI)" with 38 trials sponsored, "MedImmune LLC" with 3 trials sponsored, "Abbott Medical Devices" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Driscoll Childrens Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 115 trials as a collaborator, "Children's Oncology Group" with 5 trials as a collaborator, "Driscoll Children's Hospital" with 2 trials as a collaborator, "Pfizer" with 2 trials as a collaborator and "Children's Cancer and Leukaemia Group" with 1 trials as a collaborator. Other collaborators include 10 different institutions and companies that were collaborators in the rest 20 trials.

Clinical Trials Conditions at Driscoll Childrens Hospital


According to Clinical.Site data, the most researched conditions in "Driscoll Childrens Hospital" are "Acute Lymphoblastic Leukemia" (13 trials), "Leukemia" (11 trials), "Recurrent Neuroblastoma" (10 trials), "Recurrent Osteosarcoma" (9 trials) and "Neuroblastoma" (7 trials). Many other conditions were trialed in "Driscoll Childrens Hospital" in a lesser frequency.

Clinical Trials Intervention Types at Driscoll Childrens Hospital


Most popular intervention types in "Driscoll Childrens Hospital" are "Drug" (126 trials), "Other" (96 trials), "Biological" (59 trials), "Procedure" (58 trials) and "Radiation" (48 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (55 trials), "Cyclophosphamide" (40 trials), "Vincristine Sulfate" (34 trials), "Etoposide" (29 trials) and "Doxorubicin Hydrochloride" (27 trials). Other intervention names were less common.

Clinical Trials Genders at Driscoll Childrens Hospital


The vast majority of trials in "Driscoll Childrens Hospital" are 176 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Clinical Trials Status at Driscoll Childrens Hospital


Currently, there are NaN active trials in "Driscoll Childrens Hospital". undefined are not yet recruiting, 35 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 82 completed trials in Driscoll Childrens Hospital, 2 suspended trials, and 3 terminated clinical trials to date.
Out of the total trials that were conducted in Driscoll Childrens Hospital, 6 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 81 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".